title: Multi-level assessment protocol (MAP) for adoption in multi-site clinical trials.
abstract: The National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN) is intended to test promising drug abuse treatment models in multi-site clinical trials, and to support adoption of new interventions into clinical practice. Using qualitative research methods we asked: How might the technology of multi-site clinical trials be modified to better support adoption of tested interventions? A total of 42 participants, representing 8 organizational levels ranging from clinic staff to clinical trial leaders, were interviewed about their role in the clinical trial, its interactions with clinics, and intervention adoption. Among eight clinics participating in the clinical trial, we found adoption of the tested intervention in one clinic only. In analysis of interview data we identified four conceptual themes which are likely to affect adoption and may be informative in future multi-site clinical trials. We offer the conclusion that planning for adoption in the early stages of protocol development will better serve the aim of integrating new interventions into practice.
authors.forename: J
authors.initials: J
authors.lastname: Guydish
authors.forename: S T
authors.initials: ST
authors.lastname: Manser
authors.forename: M
authors.initials: M
authors.lastname: Jessup
authors.forename: B
authors.initials: B
authors.lastname: Tajima
authors.forename: C
authors.initials: C
authors.lastname: Sears
authors.forename: T
authors.initials: T
authors.lastname: Montini